Lobbying Spend
—
Filings
12
Firms Hired
1
Active Period
2020–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Helping Experts Accelerate Rare Treatments Act of 2022
2022 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 6888, Helping Experts Accelerate Rare Treatments Act of 2022 drug and medical device user fee reauthorization
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6888
Helping Experts Accelerate Rare Treatments Act of 2022
2022 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 6888, Helping Experts Accelerate Rare Treatments Act of 2022 drug and medical device user fee reauthorization
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6888
Helping Experts Accelerate Rare Treatments Act of 2022
2022 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 6888, Helping Experts Accelerate Rare Treatments Act of 2022 drug and medical device user fee reauthorization
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6888
Helping Experts Accelerate Rare Treatments Act of 2022
2022 · second_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 6888, Helping Experts Accelerate Rare Treatments Act of 2022 drug and medical device user fee reauthorization
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6888
Helping Experts Accelerate Rare Treatments Act of 2022
2022 · first_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 6888, Helping Experts Accelerate Rare Treatments Act of 2022
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6888
Helping Experts Accelerate Rare Treatments Act of 2021
2021 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: — · Firm income: —
Matched citations: H.R. 1184
Helping Experts Accelerate Rare Treatments Act of 2021
2021 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1184
Helping Experts Accelerate Rare Treatments Act of 2021
2021 · second_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1184
Helping Experts Accelerate Rare Treatments Act of 2021
2021 · first_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1184
Helping Experts Accelerate Rare Treatments Act of 2020
2020 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7567
Access to Rare Indications Act of 2020
2020 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases
Client expense: — · Firm income: $20,000
Matched citations: H.R. 8467
Access to Rare Indications Act of 2020
2020 · fourth_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 8467, Access to Rare Indications Act of 2020
Client expense: — · Firm income: $20,000
Matched citations: H.R. 8467
Helping Experts Accelerate Rare Treatments Act of 2020
2020 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases
Client expense: — · Firm income: $20,000
Matched citations: H.R. 7567
Access to Rare Indications Act of 2020
2020 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 8467, Access to Rare Indications Act of 2020
Client expense: — · Firm income: $20,000
Matched citations: H.R. 8467
Access to Rare Indications Act of 2020
2020 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases
Client expense: — · Firm income: $20,000
Matched citations: H.R. 8467
Helping Experts Accelerate Rare Treatments Act of 2020
2020 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases H.R. 8467, Access to Rare Indications Act of 2020
Client expense: — · Firm income: —
Matched citations: H.R. 7567
Helping Experts Accelerate Rare Treatments Act of 2020
2020 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases H.R. 8467, Access to Rare Indications Act of 2020
Client expense: — · Firm income: —
Matched citations: H.R. 7567
Access to Rare Indications Act of 2020
2020 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases H.R. 8467, Access to Rare Indications Act of 2020
Client expense: — · Firm income: —
Matched citations: H.R. 8467
Access to Rare Indications Act of 2020
2020 · third_quarter · Firm: ALPINE GROUP PARTNERS, LLC.
H.R. 7567, Helping Experts Accelerate Rare Treatments Act of 2020 H.R. 8467, Access to Rare Indications Act of 2020 Issues related to utilization management tools and rare diseases H.R. 8467, Access to Rare Indications Act of 2020
Client expense: — · Firm income: —
Matched citations: H.R. 8467
Source: Senate LDA